Voya Investment Management LLC Ideaya Biosciences, Inc. Transaction History

Voya Investment Management LLC

  • $82.2 Billion
  • Q2 2025

A detailed history of Voya Investment Management LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 23,272 shares of IDYA stock, worth $548,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,272
Previous 23,018 1.1%
Holding current value
$548,986
Previous $377,000 29.71%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$14.5 - $22.63 $3,683 - $5,748
254 Added 1.1%
23,272 $489,000
Q1 2025

May 15, 2025
SELL
$16.38 - $26.0 $479,852 - $761,670
-29,295 Reduced 56.0%
23,018 $377,000
Q4 2024

Feb 14, 2025
SELL
$24.79 - $31.98 $6.98 Million - $9.01 Million
-281,664 Reduced 84.34%
52,313 $1.34 Million
Q3 2024

Feb 07, 2025
BUY
$30.37 - $43.05 $2 Million - $2.83 Million
65,828 Added 24.55%
333,977 $10.6 Million
Q3 2024

Nov 14, 2024
BUY
$30.37 - $43.05 $1.96 Million - $2.78 Million
64,684 Added 24.77%
325,808 $10.3 Million
Q2 2024

Feb 07, 2025
BUY
$34.37 - $43.46 $2.96 Million - $3.75 Million
86,230 Added 47.4%
268,149 $9.41 Million
Q2 2024

Dec 03, 2024
SELL
$34.37 - $43.46 $2.22 Million - $2.81 Million
-64,684 Reduced 19.85%
261,124 $9.17 Million
Q2 2024

Aug 14, 2024
BUY
$34.37 - $43.46 $2.72 Million - $3.44 Million
79,205 Added 43.54%
261,124 $9.17 Million
Q1 2024

Feb 07, 2025
SELL
$34.2 - $47.13 $4.92 Million - $6.78 Million
-143,889 Reduced 44.16%
181,919 $7.98 Million
Q1 2024

Dec 06, 2024
SELL
$34.2 - $47.13 $4.92 Million - $6.78 Million
-143,889 Reduced 44.16%
181,919 $7.98 Million
Q1 2024

May 15, 2024
SELL
$34.2 - $47.13 $1.3 Million - $1.79 Million
-38,038 Reduced 17.29%
181,919 $7.98 Million
Q4 2023

Feb 07, 2025
SELL
$24.59 - $35.83 $1.75 Million - $2.55 Million
-71,119 Reduced 24.43%
219,957 $7.83 Million
Q4 2023

Feb 14, 2024
SELL
$24.59 - $35.83 $1.75 Million - $2.55 Million
-71,119 Reduced 24.43%
219,957 $7.83 Million
Q3 2023

Feb 07, 2025
BUY
$21.07 - $29.77 $144,308 - $203,894
6,849 Added 2.41%
291,076 $7.85 Million
Q3 2023

Nov 14, 2023
BUY
$21.07 - $29.77 $144,308 - $203,894
6,849 Added 2.41%
291,076 $7.85 Million
Q2 2023

Feb 07, 2025
BUY
$13.33 - $25.53 $3.57 Million - $6.84 Million
268,012 Added 1652.86%
284,227 $6.68 Million
Q2 2023

Aug 14, 2023
BUY
$13.33 - $25.53 $3.57 Million - $6.84 Million
268,012 Added 1652.86%
284,227 $6.68 Million
Q1 2023

Feb 07, 2025
SELL
$13.49 - $18.72 $4.18 Million - $5.8 Million
-309,593 Reduced 95.02%
16,215 $222,000
Q4 2022

Feb 07, 2025
BUY
$14.47 - $18.17 $22,124 - $27,781
1,529 Added 10.41%
16,215 $294,000
Q4 2022

Feb 14, 2023
BUY
$14.47 - $18.17 $22,124 - $27,781
1,529 Added 10.41%
16,215 $294,000
Q3 2022

Feb 07, 2025
SELL
$9.24 - $15.79 $2.87 Million - $4.91 Million
-311,122 Reduced 95.49%
14,686 $219,000
Q3 2022

Mar 03, 2023
SELL
$9.24 - $15.79 $14,127 - $24,142
-1,529 Reduced 9.43%
14,686 $219,000
Q3 2022

Nov 14, 2022
BUY
$9.24 - $15.79 $10,875 - $18,584
1,177 Added 8.71%
14,686 $219,000
Q2 2022

Aug 15, 2022
BUY
$8.28 - $13.88 $5,696 - $9,549
688 Added 5.37%
13,509 $186,000
Q4 2021

Feb 14, 2022
SELL
$20.95 - $26.88 $2.22 Million - $2.84 Million
-105,798 Reduced 89.19%
12,821 $303,000
Q3 2021

Nov 15, 2021
BUY
$17.26 - $27.08 $1.86 Million - $2.91 Million
107,570 Added 973.57%
118,619 $3.02 Million
Q2 2021

Aug 16, 2021
BUY
$17.76 - $24.83 $196,230 - $274,346
11,049 New
11,049 $232,000

Others Institutions Holding IDYA

# of Institutions
218
Shares Held
83.4M
Call Options Held
28.7K
Put Options Held
132K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.13B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email